Moderna Introduces AI Academy in Collaboration with CMU

Moderna, Inc., a biotechnology firm that pioneered mRNA (messenger RNA) vaccines and therapies, today announced the start of its AI (Artificial Intelligence) Academy, an innovative program that will deliver an immersive learning experience for workers in collaboration with CMU (Carnegie Mellon University).The AI Academy seeks to empower and educate workers at all levels in order to apply and identify ML and AI solutions into every procedure and system for providing mRNA medications to patients.

“Moderna is pushing mRNA therapeutics at unparalleled speed, breadth, and scale in the biopharmaceutical industry,” said Stéphane Bancel, CEO of Moderna.This one-of-a-kind program will provide a personalized curriculum designed for working professionals on subjects such as data quality and visualization, statistical reasoning and models, machine learning algorithms, and AI ethics.

The breadth and depth of knowledge will assist all employees in strategizing how to use AI in their individual job activities. The AI Academy will connect Moderna workers with CMU academics both online and in-person using the ISLE (Integrated Statistics Learning Environment). According to U.S. News & World Report, CMU is the best university for graduate studies in AI and computer science.

“We are thrilled to provide Moderna with a world-class AI curriculum and to support the company’s profound commitment to research and innovation that promotes public health,” said CMU President Farnam Jahanian. “Carnegie Mellon, with decades of field expertise, is well-positioned to assist businesses in learning how to apply AI to create the types of breakthroughs required addressing important social concerns.”